Early on, semaglutide is: Adjusting appetite and fullness Helping stabilize blood sugar Slowing digestion and food movement Those changes lay the foundation for sustainable loss, but the scale doesnt always move dramatically right away
As I was watching the Super Bowl last night, I knew that GLP-1 ads would have to make an appearance, but something about the one that aired with Serena Williams almost made me toss my coffee table, Teresa Guidice style
You can reduce severity by building good nutrition habits before treatment begins
And the treatment discontinuation rate due to adverse events rose to approximately 6%, still reasonable but six times higher than cagrilintide monotherapy
A typical transition timeline might look like this: Weeks 1-4: Start tirzepatide 2.5 mg weekly while maintaining phentermine at current dose Weeks 5-8: Increase tirzepatide to 5 mg weekly, reduce phentermine to 15 mg daily (if currently on a higher dose) Weeks 9-12: Increase tirzepatide to 7.5 mg weekly, begin tapering phentermine to every other day Week 13+: Discontinue phentermine, continue tirzepatide titration as needed This is a general framework, not a prescription
